Medicine's Donald VanDevanter comments on new cystic fibrosis medication
MEDIA |
February 7, 2020 STORY BY: EDITORIAL STAFF
Cystic Fibrosis Today: Donald VanDevanter, adjunct professor of pediatrics, discussed a new medication under review by the FDA that could potentially alleviate symptoms of cystic fibrosis.
